Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

DHCNI vs TCI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TCI Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 8–2 Matrix Metrics)

TCI Overall Winner 6-Pillar Tally: DHCNI 0 – 5 TCI (1 Tie) Matrix Metrics: DHCNI 2 – 8 TCI

As of Nov 20, 2026, Transcontinental Realty Investors, Inc. (TCI) is the stronger overall head-to-head candidate over Diversified Healthcare Trust 5.625% Senior Notes due 2042 (DHCNI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DHCNI carries a Unified Composite Score of 51.2/100 (HOLD) at $16.40 (N/M Forward P/E, 0.0% operating margin), whereas TCI carries 37.0/100 (SELL) at $45.01 (19.7x Forward P/E, -19.8% operating margin).

  • Composite vs. Pillar Nuance: While DHCNI currently prints a higher short-term Unified Composite Score (51.2/100 HOLD vs. TCI 37.0/100 SELL), TCI captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-19.8% vs. 0.0% operating margin) and revenue trajectory (+8.3% vs. +0.0% YoY).
  • Technical & Structure Timing Caution: DHCNI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.9); meanwhile TCI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 33.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DHCNI vs TCI
DHCNI NASDAQ
Diversified Healthcare Trust 5.625% Senior Notes due 2042
Real Estate Investment Trusts
$16.40
-1.74% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.55β · 36% Vol
Unified Composite Score
51.2 / 100 HOLD
Tech 69.0 Fund 56.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.4%), weak momentum, RSI 44
RSI-14: 43.9 · SMA20: $16.90 · SMA50: $17.09
TCI NYSE Head-to-Head Winner
Transcontinental Realty Investors, Inc.
Real Estate Investment Trusts
$45.01
-1.66% 1D
Market Cap $395.4M
TTM Revenue $51M
Forward P/E 19.7x
Beta / 30D Vol 0.43β · 23% Vol
Unified Composite Score
37.0 / 100 SELL
Tech 21.0 Fund 33.0 Flow 50.0 Mom 30.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 34
RSI-14: 33.6 · SMA20: $48.68 · SMA50: $46.41

6-Pillar Scorecard Institutional Category Breakdown (DHCNI 0 – 5 TCI)

Columns: Metric · DHCNI · TCI
1. Valuation Multiples TCI
Forward P/E N/M 19.7x
Trailing P/E N/M 55.1x
PEG Ratio N/M N/M
EV / Revenue N/M 7.7x
2. Growth & Scale TCI
Revenue Growth (YoY) +0.0% +8.3%
Earnings Growth (YoY) +0.0% -96.4%
TTM Revenue (USD) N/A $51M
Market Cap N/A $395.4M
3. Profitability & Quality TCI
Gross Margin N/A 37.0%
Operating Margin 0.0% -19.8%
Net Profit Margin 0.0% 14.1%
Return on Equity (ROE) 0.0% 0.9%
4. Balance Sheet & Cash Flow TCI
Cash Generation (TTM) N/A $4.7M EBITDA
Cash Flow Margin N/A 9.1% EBITDA Mgn
Net Cash / Leverage 0.0% ROE $97.92 Book/Sh · 0.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat TCI
OpEx & R&D Intensity N/A 56.8% of Rev ($29M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Other Operator Real Estate Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DHCNI (2) vs TCI (8)
Institutional Metric DHCNI TCI Criterion Row Edge
Market Capitalization
Scale
N/A $395.4M Larger Scale TCI
Trailing P/E Ratio
Valuation
N/M 55.1x Lower Multiple TCI
Forward P/E Ratio
Valuation
N/M 19.7x Lower Multiple TCI
Revenue Growth (YoY)
Growth
+0.0% +8.3% Higher Growth TCI
Operating Margin (TTM)
Profitability
0.0% -19.8% Higher Margin DHCNI
Net Profit Margin
Profitability
0.0% 14.1% Higher Margin TCI
Return on Equity (ROE)
Capital Efficiency
0.0% 0.9% Higher ROE TCI
52-Week Range Position
Momentum
17% ($16–$19) 48% ($31–$60) Stronger Trend TCI
Beta / 30D Volatility
Risk Regime
0.55β · 36% Vol 0.43β · 23% Vol Lower Realized Risk TCI
Unified Institutional Score
Composite Signal
51.2 / 100 (HOLD) 37.0 / 100 (SELL) Higher Composite DHCNI
Trailing 12M Revenue (USD)
Operating Scale
N/A $51M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 37.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 7.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) $4.7M EBITDA ($97.92 Book/Sh · 0.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DHCNI +4.49 pp
DHCNI: -3.3% · TCI: -7.79%
3M Horizon TCI +27.54 pp
DHCNI: -12.25% · TCI: +15.29%
6M Horizon TCI +35.46 pp
DHCNI: -10.43% · TCI: +25.03%
1Y Horizon TCI +6.35 pp
DHCNI: -7.45% · TCI: -1.1%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DHCNI vs TCI. Trailing 12-month operating profitability (DHCNI 0.0% vs TCI -19.8%) and valuation multiples (DHCNI N/M vs TCI 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.

DHCNI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
TCI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$51M
Gross Margin37.0%
Op. Margin-19.8%
ROE / Fwd P/E0.9% · 19.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DHCNI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DHCNI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TCI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TCI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DHCNI Moat Profile Cyclical / Execution-Driven Positioning
Other Operator
Competes within the Other value chain with N/A market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
TCI Moat Profile Cyclical / Execution-Driven Positioning
Real Estate Services Operator
Competes within the Real Estate Services value chain with $395.4M market capitalization and -19.8% operating margin.
OpEx & R&D Reinvestment 56.8% of Rev ($29M)
90D Engineering Disclosures 0 Published

Investor FAQ DHCNI vs TCI Key Questions & Quantitative Answers

As of Nov 20, 2026, Transcontinental Realty Investors, Inc. (TCI) is the stronger overall head-to-head candidate over Diversified Healthcare Trust 5.625% Senior Notes due 2042 (DHCNI) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DHCNI carries a Unified Composite Score of 51.2/100 (HOLD) at $16.40 (N/M Forward P/E, 0.0% operating margin), whereas TCI carries 37.0/100 (SELL) at $45.01 (19.7x Forward P/E, -19.8% operating margin). Composite vs. Pillar Nuance: While DHCNI currently prints a higher short-term Unified Composite Score (51.2/100 HOLD vs. TCI 37.0/100 SELL), TCI captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-19.8% vs. 0.0% operating margin) and revenue trajectory (+8.3% vs. +0.0% YoY). Technical & Structure Timing Caution: DHCNI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.9); meanwhile TCI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 33.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TCI leads the Growth & Scale pillar: DHCNI posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with TCI at +8.3% YoY revenue growth and -96.4% YoY earnings growth on $51M TTM revenue (37.0% gross margin, -19.8% operating margin). On trailing 12-month operating scale, DHCNI generates N/A in USD-normalized revenue versus $51M for TCI. In operating R&D and SG&A reinvestment, DHCNI deploys N/A (0 90-day corporate R&D disclosures) versus 56.8% of Rev ($29M) (0 disclosures) for TCI.

TCI screens cheaper on headline valuation multiples. DHCNI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TCI trades at 19.7x Forward P/E, 55.1x Trailing P/E, N/M PEG, and 7.7x EV/Revenue (9.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DHCNI (0.0% ROE) versus TCI (0.9% ROE) capital efficiency.

In options market volatility and institutional positioning, DHCNI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.55β · 36% Vol realized risk). By comparison, TCI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.43β · 23% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.